Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial
Related Posts
Burns JC, Budoff MJ, Gluckman TJ, Mehran R, Brindis RG, O'Gara PT, Akagi T, Bhatt J, Gordon JB, Newburger JW. Kawasaki Disease in Adults: A[...]
Fleseriu M, Biller BMK, Webb SM, Strasburger CJ, Georgescu CE, Bidlingmaier M, Wang C, Baciu I, Casanueva FF, Gilis-Januszewska A, Hart G, Manners A, Choe[...]
Hamashima R, Tashiro M, Nakano Y, Shirahige T, Namie H, Yano H, Ito Y, Yoshida M, Hirayama T, Takeda K, Iwanaga N, Kakiuchi S, Nishi[...]